Clinical Trial Site

Key facts

Led by

A principal investigator; Form FDA 1572 for FDA-regulated drug trials

Oversight

IRB approval and sponsor monitoring for each site

Public listing

ClinicalTrials.gov locations with facility, city, state and status

Medicare routine cost coverage

National Coverage Determination 310.1, Clinical Trial Policy

What is a clinical trial site?

A site is where a trial actually happens. Participants are screened, consented, treated and followed there, and data are recorded there before being sent to the sponsor. Each site operates under a principal investigator and needs Institutional Review Board (IRB) approval before it can enroll.

Sites include academic medical centers, community hospitals, private specialty practices, dedicated research clinics and Phase 1 units. Some independent sites belong to networks or are managed by site management organizations (SMOs) that handle contracts, staffing and recruitment across many locations.

How a site is selected and activated

A typical path from site identification to first enrollment runs:

• Feasibility: the sponsor or contract research organization checks patient population, investigator experience, staff and equipment.
• Qualification: a site selection visit or remote review confirms the site can run the protocol.
• Startup: contracts and budgets are negotiated and IRB approval is obtained.
• Activation: a site initiation visit trains staff, and the site opens to enrollment.
• Conduct and closeout: monitors review data during the trial, and the site is closed after the last participant visit.

Why trial sites matter

Slow enrollment is one of the most common reasons trials run late, and it depends on choosing sites with access to eligible patients. Feasibility teams mine trial location histories to find institutions and investigators with experience in a disease, and to avoid areas already crowded with competing trials.

Site location also shapes who can join. Travel distance limits participation for rural patients, which is one reason sponsors add community sites and decentralized elements. Coverage rules matter too: Medicare covers routine patient costs in qualifying trials under National Coverage Determination 310.1, and the Consolidated Appropriations Act, 2021 required state Medicaid programs to cover routine patient costs in qualifying trials starting in 2022.

Limitations of trial site data

ClinicalTrials.gov location lists are entered by sponsors and are not always complete or current. Facility names are free text, so the same hospital can appear under several spellings, and linking a site to an identifier such as a CMS Certification Number or a National Provider Identifier (NPI) requires matching on name and address.